Base-modified thymidines capable of terminating DNA synthesis are novel bioactive compounds with activity in cancer cells

por Borland, Kayla M., AbdulSalam, Safnas F., Solivio, Morwena J., Burke, Matthew P., Wolfkiel, Patrick R., Lawson, Sean M., Stockman, Courtney A., Andersen, Joel M., Smith, Skyler, Tolstolutskaya, Julia N., Gurjar, Purujit N., Bercz, Aron P., Merino, Edward J., Litosh, Vladislav A.
Publicado en Bioorg Med Chem (2015)